Using Risk-Based Approaches in Protocol Planning
As the pharmaceutical industry continues to embrace science- and risk-based approaches, designing stability protocols that align with Quality by Design (QbD) and ICH Q9 principles is no longer optional. Risk-based planning in protocol development ensures that stability studies are both efficient and compliant while minimizing unnecessary testing and costs. This tutorial explains how to integrate…
Read More “Using Risk-Based Approaches in Protocol Planning” »